SAMANTHA WHITE: Open Payments
NPI 1205378056 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 24 payments from 11 companies in 2025. Trend: 2023 $491 · 2024 $55 · 2025 $562
Food & beverage: $475Education: $87
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| SCPHARMACEUTICALS INC. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Mallinckrodt Hospital Products Inc. | 2 | $54 |
| Aurinia Pharma U.S., Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Calliditas Therapeutics US Inc. | 1 | $34 |
| Amgen Inc. | 1 | $32 |
Products named: RAYALDEE, FUROSCIX, FARXIGA, TERLIVAZ, LUPKYNIS, JYNARQUE, Fabhalta, JARDIANCE.
Industry payments across FL — which companies pay providers there.
